ABC474
Anti-Fhl1 Antibody
serum, from rabbit
別名:
Four and a half LIM domains protein 1, FHL-1, Skeletal muscle LIM-protein 1, SLIM, SLIM-1
ログイン組織・契約価格を表示する
すべての画像(3)
About This Item
UNSPSCコード:
12352203
eCl@ss:
32160702
NACRES:
NA.41
クローン:
polyclonal
application:
ICC
IHC
WB
IHC
WB
化学種の反応性:
mouse, human, rat
テクニック:
immunocytochemistry: suitable
immunohistochemistry: suitable
western blot: suitable
immunohistochemistry: suitable
western blot: suitable
citations:
1
由来生物
rabbit
品質水準
抗体製品の状態
serum
抗体製品タイプ
primary antibodies
クローン
polyclonal
化学種の反応性
mouse, human, rat
テクニック
immunocytochemistry: suitable
immunohistochemistry: suitable
western blot: suitable
NCBIアクセッション番号
UniProtアクセッション番号
輸送温度
wet ice
ターゲットの翻訳後修飾
unmodified
遺伝子情報
human ... FHL1(2273)
詳細
Four and a half LIM domains protein 1 (FHL1) is also called Skeletal muscle LIM-protein 1 (SLIM-1). FHL1 has 3 isoforms; Isoform 1 is highly expressed in skeletal muscle; Isoform 2 is expressed in brain and skeletal muscle; and Isoform 3 is expressed in testis, heart and skeletal muscle. FHL1 is possibly involved in muscle development or hypertrophy and associated with X-linked dominant scapuloperoneal myopathy (SPM), X-linked myopathy with postural muscle atrophy (XMPMA), X-linked severe early-onset reducing body myopathy (RBM) and X-linked childhood-onset reducing body myopathy (CO-RBM).
免疫原
Linear peptide corresponding to amino acid sequence CRDPLQGKKYVQKDGRH of human Fhl1.
アプリケーション
Research Category
アポトーシス及び癌
アポトーシス及び癌
Research Sub Category
アポトーシス-追加
アポトーシス-追加
Detect Four & a half LIM domains protein 1 using this rabbit polyclonal antibody, Anti-Fhl1 Antibody validated for use in western blotting, ICC & IHC.
Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected Fhl1 in a panel of select tissue lysates.
Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected Fhl1 in an additional panel of select tissue lysates.
Western Blotting Analysis: A representative lot from an independent laboratory detected Fhl1 in nonanchored and anchored CasKO and Cx43KO cell lysates. A representative lot from the same independent laboratory detected Fhl1 in non-SRC transformed Cx43KO cell lysate and not in SRC transformed Cx43KO cell lysate (Shen, Y., et al. (2006). Cancer Res. 66(3):1543-1552.).
Western Blotting Analysis: A representative lot from an independent laboratory detected Fhl1 in non-SRC transformed Cx43KO cell lysate and not in SRC transformed Cx43KO cell lysate (Li, X., et al. (2008). Cancer Sci. 99(7):1326-1333.).
Immunohistochemistry Analysis: A representative lot from an independent laboratory detected Fhl1 in normal brain, kidney, liver, lung, prostate, and skin tissues and demonstrated a loss of signal in breast carcinoma, renal carcinoma, hepatocarcinoma, pulmonary carcinoma, prostatic carcinoma, and melanoma tissues (Shen, Y., et al. (2006). Cancer Res. 66(3):1543-1552.).
Immunohistochemistry Analysis: A representative lot from an independent laboratory detected Fhl1 in normal epithelium of breast, kidney, and prostate tissues, and demonstrated a loss of signal in mammary duct carcinoma, renal cell carcinoma, and prostate adenocarcinoma tissues (Li, X., et al. (2008). Cancer Sci. 99(7):1326-1333.).
Immunocytochemistry Analysis: A representative lot from an independent laboratory detected Fhl1 in non SRC transformed Cx43KO and CasKO cells and demonstrated a loss of signal in SRC transformed Cx43KO and CasKO cells (Shen, Y., et al. (2006). Cancer Res. 66(3):1543-1552.).
Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected Fhl1 in an additional panel of select tissue lysates.
Western Blotting Analysis: A representative lot from an independent laboratory detected Fhl1 in nonanchored and anchored CasKO and Cx43KO cell lysates. A representative lot from the same independent laboratory detected Fhl1 in non-SRC transformed Cx43KO cell lysate and not in SRC transformed Cx43KO cell lysate (Shen, Y., et al. (2006). Cancer Res. 66(3):1543-1552.).
Western Blotting Analysis: A representative lot from an independent laboratory detected Fhl1 in non-SRC transformed Cx43KO cell lysate and not in SRC transformed Cx43KO cell lysate (Li, X., et al. (2008). Cancer Sci. 99(7):1326-1333.).
Immunohistochemistry Analysis: A representative lot from an independent laboratory detected Fhl1 in normal brain, kidney, liver, lung, prostate, and skin tissues and demonstrated a loss of signal in breast carcinoma, renal carcinoma, hepatocarcinoma, pulmonary carcinoma, prostatic carcinoma, and melanoma tissues (Shen, Y., et al. (2006). Cancer Res. 66(3):1543-1552.).
Immunohistochemistry Analysis: A representative lot from an independent laboratory detected Fhl1 in normal epithelium of breast, kidney, and prostate tissues, and demonstrated a loss of signal in mammary duct carcinoma, renal cell carcinoma, and prostate adenocarcinoma tissues (Li, X., et al. (2008). Cancer Sci. 99(7):1326-1333.).
Immunocytochemistry Analysis: A representative lot from an independent laboratory detected Fhl1 in non SRC transformed Cx43KO and CasKO cells and demonstrated a loss of signal in SRC transformed Cx43KO and CasKO cells (Shen, Y., et al. (2006). Cancer Res. 66(3):1543-1552.).
品質
Evaluated by Western Blotting in human brain tissue lysate.
Western Blotting Analysis: A 1:1,000 dilution of this antibody detected Fhl1 in 10 µg of human brain tissue lysate.
Western Blotting Analysis: A 1:1,000 dilution of this antibody detected Fhl1 in 10 µg of human brain tissue lysate.
ターゲットの説明
~32 kDa observed. The calculated molecular weight of isoform 1 for this protein is 32 kDa; however, a dimer may be observed at ~64 kDa in some cell lysates. Uncharacterized band(s) may be observed in some cell lysates.
関連事項
Replaces: MABS405
物理的形状
Unpurified
Rabbit polyclonal in buffer containing serum with 0.05% sodium azide.
保管および安定性
Stable for 1 year at -20°C from date of receipt.
Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
免責事項
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
適切な製品が見つかりませんか。
製品選択ツール.をお試しください
保管分類コード
10 - Combustible liquids
WGK
WGK 1
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Jan Code
ABC474:
試験成績書（COA）
製品のロット番号・バッチ番号を入力して、試験成績書（COA） を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
SRC uses Cas to suppress Fhl1 in order to promote nonanchored growth and migration of tumor cells.
Shen, Yongquan, et al.
Cancer Research, 66, 1543-1552 (2006)
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）